nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ADRB2—polycystic ovary syndrome	0.833	1	CbGaD
Atenolol—Respiratory distress—Metformin—polycystic ovary syndrome	0.00156	0.0941	CcSEcCtD
Atenolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.0012	0.108	CrCbGaD
Atenolol—Pindolol—ADRB3—polycystic ovary syndrome	0.00103	0.0928	CrCbGaD
Atenolol—Ibuprofen—PLAT—polycystic ovary syndrome	0.000966	0.0871	CrCbGaD
Atenolol—Lightheadedness—Metformin—polycystic ovary syndrome	0.000884	0.0535	CcSEcCtD
Atenolol—Nasal congestion—Metformin—polycystic ovary syndrome	0.000787	0.0476	CcSEcCtD
Atenolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.000783	0.0706	CrCbGaD
Atenolol—Lethargy—Metformin—polycystic ovary syndrome	0.000732	0.0443	CcSEcCtD
Atenolol—Pain in extremity—Metformin—polycystic ovary syndrome	0.000717	0.0434	CcSEcCtD
Atenolol—Sotalol—ADRB2—polycystic ovary syndrome	0.000698	0.0629	CrCbGaD
Atenolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.000632	0.057	CrCbGaD
Atenolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000622	0.0561	CrCbGaD
Atenolol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000594	0.036	CcSEcCtD
Atenolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000561	0.0506	CrCbGaD
Atenolol—Ibuprofen—BCL2—polycystic ovary syndrome	0.000555	0.05	CrCbGaD
Atenolol—Drowsiness—Metformin—polycystic ovary syndrome	0.000553	0.0334	CcSEcCtD
Atenolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000548	0.0494	CrCbGaD
Atenolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000529	0.0477	CrCbGaD
Atenolol—Bradycardia—Metformin—polycystic ovary syndrome	0.000505	0.0306	CcSEcCtD
Atenolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000501	0.0452	CrCbGaD
Atenolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000497	0.0448	CrCbGaD
Atenolol—Flushing—Metformin—polycystic ovary syndrome	0.00046	0.0279	CcSEcCtD
Atenolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000455	0.041	CrCbGaD
Atenolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000423	0.0381	CrCbGaD
Atenolol—Vision blurred—Metformin—polycystic ovary syndrome	0.000407	0.0246	CcSEcCtD
Atenolol—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000401	0.0242	CcSEcCtD
Atenolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000391	0.0353	CrCbGaD
Atenolol—Malaise—Metformin—polycystic ovary syndrome	0.00039	0.0236	CcSEcCtD
Atenolol—Syncope—Metformin—polycystic ovary syndrome	0.000387	0.0234	CcSEcCtD
Atenolol—Palpitations—Metformin—polycystic ovary syndrome	0.000382	0.0231	CcSEcCtD
Atenolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00038	0.023	CcSEcCtD
Atenolol—Chest pain—Metformin—polycystic ovary syndrome	0.000368	0.0222	CcSEcCtD
Atenolol—Discomfort—Metformin—polycystic ovary syndrome	0.000363	0.022	CcSEcCtD
Atenolol—Oedema—Metformin—polycystic ovary syndrome	0.000353	0.0213	CcSEcCtD
Atenolol—Shock—Metformin—polycystic ovary syndrome	0.000347	0.021	CcSEcCtD
Atenolol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000345	0.0209	CcSEcCtD
Atenolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000341	0.0206	CcSEcCtD
Atenolol—Anorexia—Metformin—polycystic ovary syndrome	0.000336	0.0203	CcSEcCtD
Atenolol—Hypotension—Metformin—polycystic ovary syndrome	0.000329	0.0199	CcSEcCtD
Atenolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000317	0.0191	CcSEcCtD
Atenolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000314	0.019	CcSEcCtD
Atenolol—Somnolence—Metformin—polycystic ovary syndrome	0.000313	0.019	CcSEcCtD
Atenolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00031	0.0188	CcSEcCtD
Atenolol—Ibuprofen—PPARG—polycystic ovary syndrome	0.000308	0.0277	CrCbGaD
Atenolol—Decreased appetite—Metformin—polycystic ovary syndrome	0.000306	0.0185	CcSEcCtD
Atenolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000304	0.0184	CcSEcCtD
Atenolol—Fatigue—Metformin—polycystic ovary syndrome	0.000304	0.0184	CcSEcCtD
Atenolol—Constipation—Metformin—polycystic ovary syndrome	0.000301	0.0182	CcSEcCtD
Atenolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00029	0.0176	CcSEcCtD
Atenolol—Asthenia—Metformin—polycystic ovary syndrome	0.000253	0.0153	CcSEcCtD
Atenolol—Pruritus—Metformin—polycystic ovary syndrome	0.000249	0.0151	CcSEcCtD
Atenolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000241	0.0146	CcSEcCtD
Atenolol—Dizziness—Metformin—polycystic ovary syndrome	0.000233	0.0141	CcSEcCtD
Atenolol—Rash—Metformin—polycystic ovary syndrome	0.000222	0.0134	CcSEcCtD
Atenolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000222	0.0134	CcSEcCtD
Atenolol—Headache—Metformin—polycystic ovary syndrome	0.000221	0.0134	CcSEcCtD
Atenolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000213	0.0192	CrCbGaD
Atenolol—Nausea—Metformin—polycystic ovary syndrome	0.000209	0.0127	CcSEcCtD
Atenolol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000191	0.00137	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000188	0.00135	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000186	0.00133	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000184	0.00132	CbGpPWpGaD
Atenolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000183	0.0165	CrCbGaD
Atenolol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000182	0.0013	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000182	0.0013	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000179	0.00129	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000179	0.00128	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000178	0.00127	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000175	0.00126	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000175	0.00125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000175	0.00125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000175	0.00125	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000175	0.00125	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000175	0.00125	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000174	0.00125	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000171	0.00123	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000171	0.00123	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000171	0.00122	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00017	0.00122	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000166	0.00119	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000165	0.00118	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000165	0.00118	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000162	0.00116	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000162	0.00116	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000161	0.00116	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000161	0.00116	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000161	0.00115	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000159	0.00114	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000158	0.00113	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000156	0.00112	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000154	0.00111	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000151	0.00108	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00015	0.00107	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00015	0.00107	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00015	0.00107	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000146	0.00105	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000146	0.00105	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000146	0.00105	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000146	0.00104	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000142	0.00102	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000141	0.00101	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00014	0.001	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000137	0.000984	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000137	0.000982	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000136	0.000975	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000134	0.000959	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000133	0.000956	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000133	0.000953	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000132	0.00095	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000132	0.000948	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00013	0.000929	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000129	0.000927	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000127	0.000912	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000123	0.000879	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000121	0.000869	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000121	0.000865	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00012	0.000863	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00012	0.00086	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000119	0.00085	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000118	0.000846	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000118	0.000844	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00011	0.000791	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00011	0.000786	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000108	0.000774	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000107	0.000768	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000106	0.000762	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000106	0.00076	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000105	0.000753	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000104	0.000745	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000104	0.000745	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000104	0.000743	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000103	0.000736	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000103	0.000736	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000101	0.000728	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.0001	0.00072	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0001	0.000719	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.83e-05	0.000705	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.8e-05	0.000703	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.65e-05	0.000692	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.62e-05	0.00069	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.58e-05	0.000687	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	9.53e-05	0.000683	CbGpPWpGaD
Atenolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	9.44e-05	0.000677	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	9.44e-05	0.000677	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.41e-05	0.000675	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.38e-05	0.000673	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.37e-05	0.000672	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	9.32e-05	0.000669	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.32e-05	0.000668	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	9.21e-05	0.00066	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	9.18e-05	0.000658	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.11e-05	0.000653	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	8.93e-05	0.00064	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	8.85e-05	0.000635	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.84e-05	0.000634	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.84e-05	0.000634	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	8.74e-05	0.000626	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.65e-05	0.00062	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.65e-05	0.00062	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.52e-05	0.000611	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.33e-05	0.000598	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.32e-05	0.000597	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.27e-05	0.000593	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	8.24e-05	0.000591	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	8.18e-05	0.000586	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.14e-05	0.000584	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.09e-05	0.00058	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.03e-05	0.000576	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.85e-05	0.000563	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.81e-05	0.00056	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.64e-05	0.000548	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	7.61e-05	0.000546	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	7.54e-05	0.00054	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	7.54e-05	0.00054	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	7.45e-05	0.000534	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.11e-05	0.00051	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	7.01e-05	0.000502	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.95e-05	0.000498	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.93e-05	0.000497	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.78e-05	0.000486	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	6.47e-05	0.000464	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	6.34e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.33e-05	0.000454	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.29e-05	0.000451	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.2e-05	0.000444	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	6.18e-05	0.000443	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.16e-05	0.000441	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.08e-05	0.000436	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	5.96e-05	0.000427	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	5.96e-05	0.000427	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.95e-05	0.000427	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.92e-05	0.000424	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.79e-05	0.000415	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.77e-05	0.000414	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.74e-05	0.000411	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.7e-05	0.000409	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.64e-05	0.000405	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	5.63e-05	0.000404	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.57e-05	0.0004	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.51e-05	0.000395	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.5e-05	0.000395	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	5.39e-05	0.000387	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.38e-05	0.000386	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.33e-05	0.000382	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.32e-05	0.000381	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.31e-05	0.000381	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	5.28e-05	0.000378	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.21e-05	0.000374	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.21e-05	0.000373	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.2e-05	0.000373	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	5.16e-05	0.00037	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.03e-05	0.000361	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	4.99e-05	0.000358	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.95e-05	0.000355	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.93e-05	0.000354	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.92e-05	0.000353	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.9e-05	0.000352	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.84e-05	0.000347	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.83e-05	0.000346	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.8e-05	0.000344	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	4.73e-05	0.000339	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.72e-05	0.000339	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.58e-05	0.000328	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.52e-05	0.000324	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—STAR—polycystic ovary syndrome	4.51e-05	0.000324	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.51e-05	0.000324	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.48e-05	0.000321	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.42e-05	0.000317	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	4.32e-05	0.00031	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.22e-05	0.000303	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.1e-05	0.000294	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.04e-05	0.00029	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.03e-05	0.000289	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	4.02e-05	0.000289	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.01e-05	0.000288	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	4e-05	0.000287	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.95e-05	0.000283	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.91e-05	0.00028	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.84e-05	0.000275	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.79e-05	0.000272	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.72e-05	0.000267	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.72e-05	0.000267	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.64e-05	0.000261	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.64e-05	0.000261	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.58e-05	0.000257	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.55e-05	0.000254	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.5e-05	0.000251	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—LHB—polycystic ovary syndrome	3.5e-05	0.000251	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.47e-05	0.000249	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.46e-05	0.000248	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.44e-05	0.000247	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	3.42e-05	0.000245	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.38e-05	0.000243	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.37e-05	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	3.31e-05	0.000238	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.27e-05	0.000235	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.25e-05	0.000233	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	3.24e-05	0.000233	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.2e-05	0.00023	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.18e-05	0.000228	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.17e-05	0.000228	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.13e-05	0.000224	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.08e-05	0.000221	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.06e-05	0.000219	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	3.05e-05	0.000219	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.95e-05	0.000212	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.85e-05	0.000205	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.79e-05	0.0002	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.74e-05	0.000196	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.72e-05	0.000195	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.7e-05	0.000194	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.67e-05	0.000191	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.66e-05	0.000191	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.61e-05	0.000187	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.55e-05	0.000183	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.51e-05	0.00018	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.29e-05	0.000164	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.24e-05	0.00016	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.24e-05	0.00016	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.19e-05	0.000157	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.17e-05	0.000156	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.11e-05	0.000152	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.99e-05	0.000143	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.99e-05	0.000143	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.95e-05	0.00014	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.92e-05	0.000138	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.91e-05	0.000137	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.88e-05	0.000135	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.87e-05	0.000134	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.85e-05	0.000133	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.85e-05	0.000132	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.77e-05	0.000127	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.75e-05	0.000126	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.72e-05	0.000123	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.69e-05	0.000121	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.6e-05	0.000115	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.49e-05	0.000107	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.41e-05	0.000101	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.38e-05	9.91e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.21e-05	8.68e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.21e-05	8.65e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.19e-05	8.56e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.19e-05	8.52e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.18e-05	8.47e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	8.35e-06	5.99e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	8.17e-06	5.86e-05	CbGpPWpGaD
